D-Wave Quantum (NYSE: QBTS) closed at $11.83 on October 19, 2026, less than half the $26.15 price it held at the end of 2025, leaving the stock deeply out of favor heading into a critical stretch.
Management has told investors that the fourth quarter will deliver “the majority of the year’s total revenue,” a statement that puts enormous pressure on a single three-month window to validate the entire year.
Wall Street analysts expect roughly $32 million in Q4 revenue alone, a figure that represents more than five times the $5.94 million D-Wave recognized across the entire first half of 2026.
That consensus estimate sits within a full-year 2026 forecast of approximately $42 million, a number that has barely shifted since June 30, moving only from $42.57 million to $42.47 million.
A securities class action lawsuit filed October 15 in federal court in Northern California has added legal pressure, covering buyers from February 26 to August 25, 2026, and alleging the company overstated its business and financial prospects.
The complaint cites two specific stock drops: a 9.28% decline on August 6 when Q2 revenue of $3.08 million missed the $4.03 million consensus, and a 9.51% slide on August 26 following the announced retirement of CFO John Markovich.
Sector-wide turbulence compounded the pressure after IonQ (IONQ) priced a $2 billion equity offering on October 14, days after agreeing to an all-stock acquisition deal worth up to $1.3 billion, sending D-Wave and Rigetti Computing (RGTI) each down roughly 4% in intraday trading.
Dilution anxiety is real, though D-Wave carries a meaningful buffer, holding $546.2 million in cash and marketable securities as of June 30 and selling no shares through at-the-market offerings in the first half of 2026, after issuing approximately 51 million shares in the same period a year earlier.
On the August 6 earnings call, Markovich guided Q4 revenue “up significantly over the third quarter revenue and comprising the majority of the year’s total revenue,” language that technically sets a low bar given Q1 came in at $2.86 million and Q2 at just $3.08 million.
The company’s backlog offers some visibility, with roughly 57% of a $40.7 million backlog expected to convert within 12 months, amounting to approximately $23 million, though consensus for the July 2026 through June 2027 period reaches around $65 million.
D-Wave’s systems are priced between $20 million and $40 million, with management noting that revenue on those systems is recognized over approximately two quarters once a customer site is ready.
On October 15, the company announced that an Advantage2 system had arrived in Como, Italy, under a deal worth approximately €10 million, giving Swiss Quantum Technology 50% of its capacity for five years alongside a purchase option.
CEO Alan Baratz has pushed back on the idea that the stock is purely speculative, stating “we are not asking the market to evaluate D-Wave solely on a distant promise,” though he does not expect significant gate-model cloud revenue until “the 2032 time frame.”
Production applications generated more than 37% of first-half quantum computing as a service revenue, up sharply from 9.8% in the same period a year earlier, suggesting genuine commercial traction is building even as headline numbers disappoint.
Analyst ratings have held relatively steady at 14 Buys, 1 Outperform, and 2 Holds, though the mean price target has slipped to $34.65 from $38.50 at the end of 2025, with even the lowest target of $18.36 sitting approximately 55% above the October 19 close.
As of October 16, D-Wave traded at 59.75 times next-twelve-month enterprise value to revenue, near Xanadu Quantum Technologies at 58.05 times and well below BTQ Technologies at 135.80 times.
The Q3 report, expected in early November and the first since Markovich’s September 2 departure, will be watched closely for confirmation that both annealing systems remain on track to ship in Q4 and that the 17-qubit dual-rail system Baratz described as on schedule for year-end is still on course.
A fourth-quarter result near $10 million would technically satisfy management’s own guidance language while missing the $32 million Wall Street consensus by roughly two-thirds, a gap that would severely test analyst conviction and likely force significant target reductions.
